KIRKLAND, Wash.--(BUSINESS WIRE)--Signostics, the global innovator in smart, high reliability ultrasound devices for urology, announced today that it has received U.S. Food and Drug Administration ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Uscan (Signostics), the first smart mobile-connected ultrasound device for use in urologic care, according to a company news ...
SEATTLE, Sept. 28, 2017 (GLOBE NEWSWIRE) — EchoNous, the parent company of Signostics, today announced a new $35 million dollar investment from KKR, a leading global investment firm. Building on KKR’s ...
SEATTLE, Sept. 28, 2017 (GLOBE NEWSWIRE) -- EchoNous, the parent company of Signostics, today announced a new $35 million dollar investment from KKR, a leading global investment firm. Building on ...